1. Home
  2. DCGO vs ELOX Comparison

DCGO vs ELOX Comparison

Compare DCGO & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DocGo Inc.

DCGO

DocGo Inc.

HOLD

Current Price

$0.60

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$11.81

Market Cap

43.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DCGO
ELOX
Founded
2015
N/A
Country
United States
United States
Employees
N/A
7
Industry
Managed Health Care
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
43.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DCGO
ELOX
Price
$0.60
$11.81
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
1.3M
48.2K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$322,196,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$10.00
52 Week High
$1.78
$15.00

Technical Indicators

Market Signals
Indicator
DCGO
ELOX
Relative Strength Index (RSI) 57.74 38.06
Support Level $0.47 N/A
Resistance Level $0.65 $15.00
Average True Range (ATR) 0.05 2.29
MACD 0.01 -0.09
Stochastic Oscillator 91.21 27.50

Price Performance

Historical Comparison
DCGO
ELOX

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: